Effect of dietary supplementation of (-)-epigallocatechin gallate on gut microbiota and biomarkers of colonic fermentation in rats

Journal of Nutritional Science and Vitaminology

Volumn 60, Issue 3, 2014, Pages 213-219

  Unno, Tomonori ^a   Sakuma, Mina ^a   Mitsuhashi, Shiho ^a  

^a TOKYO KASEI GAKUIN UNIVERSITY   (Japan)

Author keywords

( ) epigallocatechin gallate; Clostridium; Gut microbiota; P cresol; Short chain fatty acids

Indexed keywords

4-CRESOL; ACETIC ACID; BIOLOGICAL MARKER; BUTYRIC ACID; CATECHIN; CRESOL; EPIGALLOCATECHIN GALLATE;

ANALOGS AND DERIVATIVES; ANIMAL; BIFIDOBACTERIUM; CLOSTRIDIUM; DIET SUPPLEMENTATION; DRUG EFFECTS; FECES; FERMENTATION; GASTROINTESTINAL TRACT; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGY; MICROFLORA; ORGAN SIZE; PREVOTELLA; RAT; WEIGHT GAIN; WISTAR RAT;

ACETIC ACID; ANIMALS; BIFIDOBACTERIUM; BIOLOGICAL MARKERS; BUTYRIC ACID; CATECHIN; CLOSTRIDIUM; CRESOLS; DIETARY SUPPLEMENTS; FECES; FERMENTATION; GASTROINTESTINAL TRACT; MALE; MICROBIOTA; ORGAN SIZE; PREVOTELLA; RATS; RATS, WISTAR; WEIGHT GAIN;

EID: 84905189420     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.60.213     Document Type: Article

References (34)

1. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. 2012. Diversity, stability and resilience of the human gut mcrobiota. Nature 489: 220-230.
2. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S. 2012. Host-gut microbiota metabolic interactions. Science 336: 1262-1267.
3. Tremaroli V, Bäckhed F. 2012. Functional interactions between the gut microbiota and host metabolism. Nature 489: 242-249.
4. Sonoyama K. 2010. Metabolic syndrome and gut microbiota. Chonai Saikingaku Zasshi (J Intest Microbiol) 24: 193-201 (in Japanese).
5. Gerritsen J, Smidt H, Rijkers GT, de Vos WM. 2011. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr 6: 209-240.
6. Delzenne NM, Neyrinck AM, Bäckhed F, Cani PD. 2011. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7: 639-646.
7. Brownawell AM, Caers W, Gibson GR, Kendall CW, Lewis KD, Ringel Y, Slavin JL. 2012. Prebiotics and the health benefits of fiber: current regulatory status, future research, and goals. J Nutr 142: 962-974.
8. Kemperman RA, Bolca S, Roger LC, Vaughan EE. 2010. Novel approaches for analysing gut microbes and dietary polyphenols: challenges and opportunities. Microbiology 156: 3224-3231.
9. Cardona F, Andrés-Lacueva C, Tulipani S, Tinahones FJ, Queipo-Ortuño MI. 2013. Benefits of polyphenols on gut microbiota and implications in human health. J Nutr Biochem 24: 1415-1422.
10. Etxeberria U, Fernández-Quintela A, Milagro FI, Aguirre L, Martínez JA, Portillo MP. 2013. Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition. J Agric Food Chem 61: 9517-9533.
11. Dolara P, Luceri C, De Filippo C, Femia AP, Giovannelli L, Caderni G, Cecchini C, Silvi S, Orpianesi C, Cresci A. 2005. Red wine polyphenols influence carcinogenesis, intestinal microflora, oxidative damage and gene expression profiles of colonic mucosa in F344 rats. Mutat Res 591: 237-246.
12. Queipo-Ortuño MI, Boto-Ordóñez M, Murri M, Gomez-Zumaquero JM, Clemente-Postigo M, Estruch R, Cardona Diaz F, Andrés-Lacueva C, Tinahones FJ. 2012. Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am J Clin Nutr 95: 1323-1334.
13. Tzounis X, Rodriguez-Mateos A, Vulevic J, Gibson GR, Kwik-Uribe C, Spencer JP. 2011. Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am J Clin Nutr 93: 62-72.
14. Graham HN. 1992. Green tea composition, consumption, and polyphenol chemistry. Prev Med 21: 334-350.
15. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. 2005. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81: 230S-242S.
16. Lee HC, Jenner AM, Low CS, Lee YK. 2006. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res Microbiol 157: 876-884.
17. Kudo YH, Yamasaki A, Sasaki M, Okubo T, Minai Y, Haga M, Kondo K, Konishi YS. 2005. Antibacterial action on pathogenic bacterial spore by green tea catechins. J Sci Food Agric 85: 2354-2361.
18. Unno T, Matsumoto Y, Yamamoto Y. 2012. Gallated form of tea catechins, not nongallated form, increases fecal starch excretion in rats. J Nutr Sci Vitaminol 58: 45-49.
19. Miwa H, Hiyama C, Yamamoto M. 1985. High-performance liquid chromatography of short-and long-chain fatty acids as 2-nitrophenylhydrazides. J Chromatogr 321: 165-174.
20. Nagashima K, Mochizuki J, Hisada T, Suzuki S, Shimomura K. 2006. Phylogenetic analysis of 16S ribosomal RNA gene sequences from human fecal microbiota and improved utility of terminal restriction fragment length polymorphism profiling. Biosci Microflora 25: 99-107.
21. Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, Honda K, Ishikawa Y, Hara E, Ohtani N. 2013. Obesityinduced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499: 97-101.
22. van Duynhoven J, Vaughan EE, Jacobs DM, Kemperman RA, van Velzen EJ, Gross G, Roger LC, Possemiers S, Smilde AK, Doré J, Westerhuis JA, Van de Wiele T. 2011. Metabolic fate of polyphenols in the human superorganism. Proc Natl Acad Sci USA 108: 4531-4538.
23. van't Slot G, Humpf HU. 2009. Degradation and metabolism of catechin, epigallocatechin-3-gallate (EGCG), and related compounds by the intestinal microbiota in the pig cecum model. J Agric Food Chem 57: 8041-8048.
24. Unno T, Tamemoto K, Yayabe F, Kakuda T. 2003. Urinary excretion of 5-(3e,4,-dihydroxyphenyl)-g-valerolactone, a ring-fission metabolite of (2)-epicatechin, in rats and its in vitro antioxidant activity. J Agric Food Chem 51: 6893-6898.
25. Jacobs DM, Gaudier E, van Duynhoven J, Vaughan EE. 2009. Non-digestible food ingredients, colonic microbiota and the impact on gut health and immunity: a role for metabolomics. Curr Drug Metab 10: 41-54.
26. Bone E, Tamm A, Hill M. 1976. The production of urinary phenols by gut bacteria and their possible role in the causation of large bowel cancer. Am J Clin Nutr 29: 1448-1454.
27. Meyer TM, Hostetter TH. 2012. Uremic solutes from colon microbes. Kidney Int 81: 949-954.
28. Macfarlane SM, Macfarlane GT. 2003. Regulation of short-chain fatty acid production. Proc Nutr Soc 62: 67-72.
29. Watabe J. 2005. Carbohydrate fermentation in the colon. Chonai Saikingaku Zasshi (J Intest Microbiol) 19: 167-177 (in Japanese).
30. Selma MV, Espín JC, Tomás-Barberán FA. 2009. Interaction between phenolics and gut microbiota: role in human health. J Agric Food Chem 57: 6485-6501.
31. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
32. Kajimoto O, Kajimoto Y, Yabune M, Nakamura T, Kotani K, Suzuki Y, Nozawa A, Nagata K, Unno T, Sagesaka YM, Kakuda T, Yoshikawa T. 2005. Tea catechins with a galloyl moiety reduce body weight and fat. J Health Sci 51: 161-171.
33. Ikeda I, Tsuda K, Suzuki Y, Kobayashi M, Unno T, Tomoyori H, Goto H, Kawata Y, Imaizumi K, Nozawa A, Kakuda T. 2005. Tea catechins with a galloyl moiety suppress postprandial hypertriacylglycerolemia by delaying lymphatic transport of dietary fat in rats. J Nutr 135: 155-159.
34. Rains TM, Agarwal S, Maki KC. 2011. Antiobesity effects of green tea catechins: a mechanistic review. J Nutr Biochem 22: 1-7.